DK24891A - Monoklonalt antistof til inhibering af cellers infektion med hiv-vira - Google Patents

Monoklonalt antistof til inhibering af cellers infektion med hiv-vira Download PDF

Info

Publication number
DK24891A
DK24891A DK024891A DK24891A DK24891A DK 24891 A DK24891 A DK 24891A DK 024891 A DK024891 A DK 024891A DK 24891 A DK24891 A DK 24891A DK 24891 A DK24891 A DK 24891A
Authority
DK
Denmark
Prior art keywords
vira
hiv
monoclonal antibody
inhibiting cell
cell infection
Prior art date
Application number
DK024891A
Other languages
English (en)
Other versions
DK24891D0 (da
Inventor
Gerhard Hunsmann
Wolfgang Lueke
Frank Emmrich
Original Assignee
Max Planck Gesellschaft
Deutsches Primatenzentrum Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft, Deutsches Primatenzentrum Gmbh filed Critical Max Planck Gesellschaft
Publication of DK24891D0 publication Critical patent/DK24891D0/da
Publication of DK24891A publication Critical patent/DK24891A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK024891A 1988-08-23 1991-02-13 Monoklonalt antistof til inhibering af cellers infektion med hiv-vira DK24891A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3828582A DE3828582A1 (de) 1988-08-23 1988-08-23 Monoklonaler antikoerper zur inhibierung der infektion von zellen durch hiv-viren
PCT/EP1989/000986 WO1990002199A1 (de) 1988-08-23 1989-08-22 Monoklonaler antikörper zur inhibierung der infektion von zellen durch hiv-viren

Publications (2)

Publication Number Publication Date
DK24891D0 DK24891D0 (da) 1991-02-13
DK24891A true DK24891A (da) 1991-02-13

Family

ID=6361424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK024891A DK24891A (da) 1988-08-23 1991-02-13 Monoklonalt antistof til inhibering af cellers infektion med hiv-vira

Country Status (7)

Country Link
EP (1) EP0430999A1 (da)
JP (1) JPH04501055A (da)
AU (1) AU629847B2 (da)
DE (1) DE3828582A1 (da)
DK (1) DK24891A (da)
ES (1) ES2018387A6 (da)
WO (1) WO1990002199A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919294C2 (de) * 1989-06-13 1998-04-23 Frank Prof Dr Emmrich Verwendung eines monoklonalen Antikörpers zur Behandlung einer Autoimmunerkrankung
US5961976A (en) * 1996-06-03 1999-10-05 United Biomedical, Inc. Antibodies against a host cell antigen complex for pre- and post-exposure protection from infection by HIV
EP2471543A1 (en) 2010-12-02 2012-07-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tolerance induction or immunosupression to prevent in particular Graft-versus-Host-Disease (GvHD) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
SG11201702056YA (en) 2014-09-16 2017-04-27 United Biomedical Inc Treatment and functional cure of hiv infection by monoclonal antibodies to cd4 mediating competitive hiv entry inhibition
CA3033728A1 (en) 2016-08-13 2018-02-22 Ubi Ip Holdings Treatment and sustained virologic remission of hiv infection by antibodies to cd4 in haart stabilized patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683295A (en) * 1984-05-24 1987-07-28 Scripps Clinic And Research Foundation Method for the preparation of anti-receptor antibodies
FR2570278B1 (fr) * 1984-09-14 1987-02-13 Pasteur Institut Compositions et procede pour proteger les lymphocytes t contre l'agent etiologique des lymphadenopathies et du syndrome d'immunodepression acquise
JP3134874B2 (ja) * 1986-08-21 2001-02-13 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用
FI891226L (fi) * 1988-04-28 1989-10-29 Univ Leland Stanford Junior Reseptordeterminanter i anti-t-celler foer behandling av autoimmunsjukdom.
EP0380018B1 (en) * 1989-01-23 1995-07-19 Abbott Laboratories Rat monoclonal antibodies directed against human antigens and processes for preparation thereof

Also Published As

Publication number Publication date
DK24891D0 (da) 1991-02-13
JPH04501055A (ja) 1992-02-27
WO1990002199A1 (de) 1990-03-08
AU4070289A (en) 1990-03-23
AU629847B2 (en) 1992-10-15
DE3828582A1 (de) 1990-03-01
ES2018387A6 (es) 1991-04-01
EP0430999A1 (de) 1991-06-12

Similar Documents

Publication Publication Date Title
DK666389A (da) Monoklonalt antistof
FI925631L (fi) Monoklonala antikroppar
DK473887D0 (da) Hybridomacellelinie, monoklonalt antistof, fremgangsmaade til fremstilling af og anvendelse af det monoklonale antistof
KR900702007A (ko) T세포 항원 수용체의 지어부위와 반응하는 단클론항체
DE68914244D1 (de) Monoklonaler Antikörper.
FI914908A0 (fi) Ny monoklonal antikropp med ny antigen relaterad till humana tumoerer.
DK295889D0 (da) Fremgangsmaade til sammenklaebning af materialelag
DK65185D0 (da) Fremgangsmaade til fremstilling af antistof
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DK188185A (da) Monoklonalt antistof
DK24891D0 (da) Monoklonalt antistof til inhibering af cellers infektion med hiv-vira
DK319685A (da) Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
DK437087A (da) Monoklont antistof til bestemmelse af humant glycoalbumin
DK343089D0 (da) Fremgangsmaade til fremstilling af loebeost
DK37785D0 (da) Monoclonalt antistof
DK144485A (da) Monoklonale antistoffer
DK717888A (da) Monoklonale antistoffer
DK49291D0 (da) Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer
NO890116L (no) Monoklonale antistoffer.
DK474189A (da) Monoklonalt antistof
DK134487D0 (da) Monoklonalt antistof med affinitet for humant interleukin-2
DK370089D0 (da) Anti-urokinase monoklonale antistoffer
DK338889D0 (da) Fremgangsmaade til bestemmelse af antistoffer
FI893928A7 (fi) Monoklonala motkroppar.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment